Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lessons from hypertension trials

C H Hennekens1

  • 1Harvard Medical School and the Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02215-1204, USA.

The American Journal of Medicine
|July 31, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prospective study of blood pressure and risk of cataract in men.

Annals of epidemiology·2001
Same author

G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism.

Journal of the American College of Cardiology·2001
Same author

Relations of body fat distribution and height with cataract in men.

The American journal of clinical nutrition·2000
Same author

Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men.

Hypertension (Dallas, Tex. : 1979)·2000
Same author

An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease.

Archives of internal medicine·2000
Same author

Clinical and research challenges in risk factors for cardiovascular diseases.

European heart journal·2000
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Mesenteric Panniculitis.

The American journal of medicine·2026
Same journal

Hypercalcemia and hyperferritinemia in a patient with Graves' disease disease.

The American journal of medicine·2026
See all related articles

Mild hypertension significantly increases risks for stroke and heart attack. Effective treatment involves medication and lifestyle changes, with beta blockers and diuretics recommended as initial therapies.

Area of Science:

  • Cardiology
  • Public Health

Background:

  • Hypertension is a major risk factor for stroke, myocardial infarction (MI), and cardiovascular mortality.
  • Even mild blood pressure elevations increase cardiovascular risk, with mild-to-moderate hypertension being more prevalent and contributing to a larger proportion of vascular events and deaths.

Purpose of the Study:

  • To review the risks associated with mild-to-moderate hypertension.
  • To discuss treatment strategies for hypertension, emphasizing pharmacologic therapy and lifestyle modifications.

Main Methods:

  • Literature review on hypertension, its risk factors, and treatment guidelines.
  • Analysis of the impact of mild-to-moderate hypertension on cardiovascular outcomes.

Main Results:

Related Experiment Videos

  • Pharmacologic therapy for mild-to-moderate hypertension significantly reduces the incidence of stroke, MI, coronary artery disease, and overall mortality.
  • Lifestyle modifications such as weight loss, sodium restriction, reduced alcohol intake, and increased exercise are crucial components of hypertension management.

    • Conclusions:

    • Beta blockers and diuretics are recommended as first-line antihypertensive agents pending further evidence for newer drug classes.
    • Comprehensive management combining pharmacologic treatment and lifestyle changes is essential for mitigating the risks of hypertension.